The Role of Brg1, a Catalytic Subunit of Mammalian Chromatin-remodeling Complexes, in T Cell Development by Geburhr, Thomas C. et al.
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
J. Exp. Med.  The Rockefeller University Press • 0022-1007/2003/12/1937/13 $8.00
Volume 198, Number 12, December 15, 2003 1937–1949
http://www.jem.org/cgi/doi/10.1084/jem.20030714
1937
The Role of Brg1, a Catalytic Subunit of Mammalian 
Chromatin-remodeling Complexes, in T Cell Development
Thomas C. Gebuhr,1 Grigoriy I. Kovalev,2,4 Scott Bultman,1 Virginia Godfrey,3
Lishan Su,2,4 and Terry Magnuson1,4,5
1Department of Genetics, 2Department of Microbiology and Immunology, 3Department of Pathology 
and Laboratory Medicine, 4Lineberger Comprehensive Cancer Center, and 5Carolina Center for Genome Sciences, 
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
Abstract
Mammalian SWI–SNF-related complexes use brahma-related gene 1 (Brg1) as a catalytic subunit to
remodel nucleosomes and regulate transcription. Recent biochemical data has linked Brg1
function to genes important for T lymphocyte differentiation. To investigate the role of SWI–
SNF-related complexes in this lineage, we ablated Brg1 function in T lymphocytes. T cell–specific
Brg1-deficient mice showed profound thymic abnormalities, CD4 derepression at the double
negative (DN; CD4 CD8) stage, and a developmental block at the DN to double positive
(CD4 CD8) transition. 5-bromo-2-deoxyuridine incorporation and annexin V staining
establish a role for Brg1 complexes in the regulation of thymocyte cell proliferation and survival.
This Brg1-dependent cell survival is specific for developing thymocytes as indicated by the
presence of Brg1-deficient mature T lymphocytes that have escaped the developmental block
in the thymus. However, reductions in peripheral T cell populations lead to immunodeficiency
and compromised health of mutant mice. These results highlight the importance of chromatin-
remodeling complexes at different stages in the development of a mammalian cell lineage.
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Introduction
Coordinated programs of gene expression underlie the
development, functional differentiation, and homeostatic
regulation of the mammalian immune system. Perhaps
one of the most intensely studied systems of transcriptional
regulation is that of T lymphocyte ontogeny (1). Activation
or repression of lineage-specific and developmental stage–
restricted cell surface molecules has been correlated with
cell fate choices in the  T cell differentiation pathway.
Up-regulation of both CD4 and CD8 and subsequent
down-regulation of one of these two coreceptors in devel-
oping thymocytes leads to mature T helper (CD4 CD8)
and cytotoxic (CD4 CD8) T cells in the periphery.
In addition to lineage-restricted transcription factors, it is
becoming increasingly clear that chromatin-modifying factors
are necessary to achieve proper temporal and spatial patterns
of gene expression in the immune system. Modification of
local chromatin structure is achieved, in part, through the
activity of multisubunit protein complexes that use the energy
of ATP hydrolysis to disrupt the conformation and position
of nucleosomes (2). The yeast SWI–SNF complex was the
first such complex to be identified. It has been character-
ized in the most detail and is conserved throughout evolution.
Mammalian SWI–SNF-related complexes consist of 9–11
subunits that utilize either brahma (Brm; also called SNF-
or Smarca2) or Brm-related gene 1 (Brg1; also called SNF2-
or Smarca4) as the catalytic subunit (2, 3).
Targeted mutations of the Brg1 catalytic subunit or two
other complex members (INI1–Snf5 and Srg3–Baf155) confer
early embryonic lethality in the mouse, indicating that
mammalian SWI–SNF-related complexes are essential (4–
7). Although few direct target genes have been confirmed
in mammalian cells, biochemical interactions with gene
regulatory elements and transcription factors important for
hematopoietic lineage specification have implicated SWI–
SNF-related function in these processes (8). For example,T.C. Gebuhr and G.I. Kovalev contributed equally to this work.
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interactions of chromatin-modifying complexes, including
SWI–SNF-related, with Ikaros, a zinc finger–containing, se-
quence-specific DNA-binding transcription factor impor-
tant in lymphocyte development, suggest a link between
chromatin regulation and hematopoietic cell fate decisions
(9). Consistent with this notion, chromatin immunoprecipi-
tation assays have correlated down-regulation of IL-2R
(CD25) at the double negative (DN) stages of T cell devel-
opment with the dissociation of Brg1 and histone acetylase
p300 from promoter elements (10). Moreover, dominant
negative expression of BAF57, an HMG-containing, DNA-
binding subunit of the SWI–SNF-related complexes, in the
T cell lineage revealed a role of chromatin remodeling in
CD4 silencing and CD8 activation (11). These data provide
evidence that SWI–SNF-related complexes are important
regulators of stage-restricted gene expression in the T cell
lineage. In addition to this developmental gene regulation,
chromatin-modifying activity has been associated with
proliferation of peripheral T lymphocytes. For example,
antigenic activation of T cells induces rapid association of
SWI–SNF-related complexes with chromatin in a Brg1-
dependent manner (12). Furthermore, inactivation of Lsh, a
member of the SNF2 family of proteins including Brg1, in
lymphoid precursors results in a severe proliferation defect
in response to Con A activation of peripheral T lympho-
cytes (13). Thus, chromatin-remodeling activity has been
associated with a number of processes in T cell development
and function, although the early lethality or minimal phe-
notypes associated with targeted mutations in SWI–SNF-
related complex members do not permit loss of function
studies in this lineage.
To investigate the in vivo role of Brg1 and the SWI–
SNF-related complex function in T cell biology, we specif-
ically inactivated Brg1
 
 in the T cell lineage using the Cre-
 
lox
 
P conditional mutagenesis system. Here, we report that
loss of Brg1 results in a block in T cell development at the
immature stages and investigate the effect of Brg1 mutation
on mature T cells in the periphery. These data provide in
vivo evidence implicating ATP-dependent chromatin-remod-
eling factors as important regulators of T lymphocyte de-
velopment and immune response.
Materials and Methods
Mice. The Brg1 germline-null allele (4), the lck-Cre (14), and
the Zp3-Cre (15) mice have been described. The Brg1 floxed al-
lele mice were provided by P. Chambon (Centre National de la
Recherche Scientifique, Strasbourg, France) and harbor previ-
ously described loxP sites integrated into the Brg1 genomic locus
(16). All mice were maintained on a mixed genetic background at
the University of North Carolina, Chapel Hill Animal Facility.
Genotyping, RT-PCR, and PCR Quantification. Genotyping
for the Brg1-targeted mutation has been described (4). For the
detection of the lck-Cre and Zp3-Cre transgenes, similar condi-
tions were used except for 1.5 mM MgCl2, 62C annealing tem-
perature, and the following primers specific for Cre: forward,
5caatttactgaccgtacac3; reverse, 5catcgccatcttccagcag3. For the
amplification of the unrecombined and recombined floxed allele
depicted in Fig. 1 B the sequences are: primer 1, 5-gatcagctcat-
gccctaagg-3; primer 2, 5-gtcatacttatgtcatagcc-3; and primer 3,
5-gccttgtctcaaactgataag-3 (1 mM MgCl2 and 51C annealing).
RT-PCR conditions for Brm, TCR, and CD3 have been re-
ported (4, 17, 18).
Quantification of PCR products was performed on a GelDoc
2000 (Bio-Rad Laboratories) using Multianalyst software (Bio-Rad
Laboratories; see Supplemental Materials and Methods, available at
http://www.jem.org/cgi/content/full/jem.20030714/DC1).
Antibodies, Cell Labeling, and FACS® Assays. mAbs used for
immunofluorescence are listed in Supplemental Materials and
Methods, available at http://www.jem.org/cgi/content/full/
jem.20030714/DC1. Annexin-V/propidium iodide (PI) staining
was performed according to the manufacturer’s protocol (Roche).
LN cells were stained and analyzed on a FACScan™ flow cytome-
ter (BD Biosciences). Cell sorting was performed on a MoFlow
(DakoCytomation) instrument. The FACS® data were analyzed
with the Summit V3.1 data analysis software (DakoCytomation).
Histology. Thymi from 4-wk-old animals and livers from
3–6-mo-old animals were dissected, fixed in 4% paraformaldehyde,
and processed for the production of paraffin sections. 5–8-	m
sections were stained with hematoxylin and eosin using standard
conditions.
In vivo 5-bromo-2-deoxyuridine (BrdU) Labeling and Anti-BrdU
Staining. BrdU (Sigma-Aldrich) was administrated by intraperi-
toneal administration of 1 mg/mouse injected two times 4 h apart
as previously described (19). Thymocytes were harvested in 1 h
after the second injection and stained with anti-CD4 and anti-
CD8 mAbs. The BrdU staining of those cells was performed by a
conventionally modified method as previously described (19).
Cell Activation and Proliferation Assays. The complete medium
(RPMI 1640 supplemented with 10% FCS, 2 mM l-glutamine,
50 U/ml pen/strep) was used for cell culture. CD3 and CD3/
CD28 stimulation was performed as previously described (20).
For in vitro mitogen stimulation, 5 
 105 LN cells were cultured
in 200 	l medium, with or without 5 or 10 	g/ml Con A
(Sigma-Aldrich), or with 0.5 ng/ml PMA and 0.5 	M ionomy-
cin in 96-well flat-bottom plates. Incubation was performed in
complete RPMI for 48 h in 37C with pulse [H3]thymidine at 1
uCi/well for the last 12 h.
Online Supplemental Material. See Supplemental Materials and
Methods, available at http://www.jem.org/cgi/content/full/
jem.20030714/DC1, for details regarding genotyping, RT-PCR,
and PCR quantification.
Results
Generation of T Cell–specific Brg1-deficient Mice. To in-
vestigate the potential function of Brg1 during thymocyte
development, we used a previously described Brg1
“floxed” allele in which loxP sites flank exons that encode a
portion of the conserved ATPase domain (Fig. 1 A; refer-
ences 4 and 16). Cre-mediated recombination of the loxP
sites creates a deletion corresponding to the putative ATP
hydrolysis site and also introduces a frameshift mutation.
This “ floxed” configuration encodes a COOH termi-
nally truncated protein product and is predicted to be a null
allele, which was confirmed by crossing the floxed allele to
a Zp3-Cre transgenic mouse that recombines loxP sites in
the female germline (15). Constitutive  floxed/ inter-
crosses failed to yield  floxed/ floxed homozygotes and
no homozygotes were recovered upon dissection of litters
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at embryonic days 7.5 and 8.5 (0/15; 0.05  P  0.025).
The fact that no resorption moles or empty decidua were
observed indicates that lethality occurs before decidualiza-
tion is initiated as reported for the targeted null allele (4).
Thus,  floxed is a null allele.
Mice carrying the Brg1 floxed allele (/flox) were
mated with mice heterozygous for a Brg1-null mutation
generated by gene targeting (/null) and mice expressing
Cre recombinase under the control of the lck-proximal
promoter (/; lck-Cre) to obtain compound heterozy-
gous mice harboring the lck-Cre transgene (null/floxed;
lck-Cre, henceforth referred to as tBrg1 for T cell lin-
eage–specific Brg1 mutation; references 4 and 14). Mice
harboring one floxed allele, one wild-type allele, and the
lck-Cre transgene (/floxed; lck-Cre) showed no differences
from wild-type mice in total thymocyte number or cell
type composition (unpublished data), consistent with pre-
viously published reports of no gross abnormalities in T cell
development in mice heterozygous for the Brg1-null muta-
tion (11). Therefore, both wild-type and /floxed; lck-Cre
mice were used as controls.
The lck-Cre transgene has previously been shown to ex-
press Cre specifically in the T cell lineage, with Cre-medi-
ated recombination detected as early as the DN1 (CD44
CD25) stage and complete by the double positive (DP;
CD4 CD8) stage (14). PCR analysis of whole thymic
DNA preparations from Brg1 /floxed; lck-Cre mice
showed efficient recombination of loxP sites, as judged by
the loss of the floxed amplicon (Fig. 1 B, top) using primers
that amplify both the wild-type and floxed allele (Fig. 1 A,
primers 2 and 3). Accordingly, the  floxed allele showed
significant amplification in thymus and not in tail DNA
preparations using primers specific for the recombined
floxed allele (Fig. 1 B, bottom, and A, primers 1 and 3). To
investigate timing of recombination of the Brg1 floxed al-
lele, we analyzed the triple negative (TN; CD4 CD8
CD3) DN1 through DN4 cell populations from Brg1
/flox; lck-Cre mice. Cre-mediated deletion began at DN1
and proceeded through DN4 (Fig. 1 C, bottom) stage,
consistent with previous reports using this lck-Cre trans-
gene (14). As shown in Fig. 1 C, top, the floxed allele was
only partially deleted at the DN1, DN2, and DN3 stages,
but was virtually complete by the DN4 stage. Loss of the
floxed allele amplicon at DN4 indicates high efficiency of
recombination by this stage.
T Cell–specific Brg1 Inactivation Resulted in Abnormal Thy-
mic Development and Runting. Gross dissection of tBrg1
mutant animals revealed severe thymic defects. The overall
size of the mutant thymus was markedly reduced compared
with the large, bi-lobed thymus observed in control litter-
mates at 4 wk of age (compare A and B in Fig. 2). Thy-
mocyte cell counts demonstrated a dramatic 20-fold reduc-
tion in total thymocytes present in the mutant thymus,
indicating a T cell developmental defect (1.3  0.7 
 107
in mutant vs. 27.3  8 
 107 in control 4-wk-old thymus;
Fig. 2 D). In support of this finding, histological analysis re-
vealed an almost complete loss of corticomedullary archi-
tecture in tBrg mutant animals (compare E and F in Fig.
2) and enlarged cortical thymocytes containing irregular
oval nuclei with more open chromatin, which is indicative
of more immature thymocytes (Fig. 2 H). Additionally,
higher magnification histological analysis revealed an in-
crease in the number of mitotic figures as well as apoptotic
bodies in the mutant thymus (compare G and H in Fig. 2).
tBrg1 mice displayed a significant reduction in body
weights at 3–4 wk of age compared with sex-matched con-
trol littermates (Fig. 2 C). Although the severity of runting
was variable between litters, differences in body weights
Figure 1. Conditional inactivation of Brg1 in developing thymocytes.
(A) Schematic representation of Brg1 floxed allele. Open triangles represent
position of loxP sites, solid boxes represent Brg1 exons, and arrows 1–3
indicate position and orientation of PCR primers used for genotype
analysis in C and D. (B) Detection of Cre-mediated deletion of the Brg1
floxed allele in thymus. PCR analysis using primers (primer set 2/3 in B)
that amplify both the wild-type and floxed allele (top) in whole thymus
DNA preparations from /floxed; lck-Cre mice. Loss of upper floxed allele
band indicates efficient recombination of loxP sites and conversion to 
floxed (bottom, primers set 1/3 in B). (C) Timing and efficiency of recombi-
nation during thymocyte development at the DN (CD4 CD8) stages.
TN (CD4 CD8 CD3) thymocytes from /floxed:lck-Cre mice were
subdivided into DN1→DN4 stages. PCR analysis as described in B allowed
for determination of timing of recombination (bottom) and efficiency of
recombination (top) at these DN stages using tail DNA as a control.
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between mutants and control animals remained relatively
constant throughout the aging process.
T Cell Developmental Block and CD4 Derepression in
tBrg1 Mice. To provide insight into the nature of the T
cell developmental defect, FACS® analysis of a number of
stage-specific cell surface markers was performed on thy-
mocytes from tBrg1 animals versus controls. Signifi-
cantly, CD4/CD8 staining revealed an almost complete
loss of the DP (CD4 CD8) and CD8 single positive (SP;
CD4 CD8) cell populations, with a corresponding rela-
tive increase in DN (CD4 CD8) T cells in the mutant
thymus (Fig. 3, A and B). Interestingly, mutant thymocytes
showed an increased percentage of CD4 SP cells, although
the absolute number of CD4 CD8 cells was reduced
(Fig. 3, B and C). In absolute numbers per thymus, DP
thymocytes were reduced 250-fold, CD4 SP fourfold, and
CD8 100-fold, whereas the total DN cell population was
largely unaffected (Fig. 3 C). Recently, SWI–SNF-related
complexes have been implicated in the coordinated tran-
scriptional regulation of CD4 (repression) and CD8 (acti-
vation) in developing thymocytes (11). Therefore, we hy-
pothesized that the CD4 SP cells present in the tBrg1
Figure 2. Thymic defects in tBrg1 mutant
mice. (A and B) Gross morphology of control (A)
versus tBrg1 mutant (B) thymi of 4-wk-old
animals. Arrows indicate bi-lobed thymus above
heart in upper thoracic cavity. Heart (Ht) and lung
(Lg) tissue are indicated. (C) Bar graph representa-
tion of mutant body weights. Bars represent averages
of tBrg1 weights at weaning from multiple litters
(left: female, n  5; right: male, n  6) expressed as
percent of wild-type body weight (littermate con-
trols). (D) Total thymic cellularity (
106) in control
versus tBrg1 mice. Solid bars represent average
values of total cell counts from individual mice ().
control, n  8; mutant mice, n  8. (E–H) Hema-
toxylin and eosin–stained sections of control (E and
G) and mutant (F and H) thymus. (F) Demonstrates
loss of cortico-medullary (M, medulla; Cx, cortex)
architecture in the mutant thymus at low magnifi-
cation (
10). (H) Arrows indicate increased apop-
totic bodies (Ap) and mitotic figures (Mt) observed
in tBrg1 thymus on higher magnification (
40).
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mutant thymus constitute an immature T cell population
that aberrantly express CD4 (derepression) at the DN stages
in the absence of Brg1 function. Examination of TCR sur-
face levels in mutant and control CD4 SP cells confirmed
this hypothesis, with 5% of CD4 mutant thymocytes
expressing high levels of the TCR compared with 90%
TCR observed in control mature CD4 SP cells (Fig. 3
D). Moreover, direct examination of CD4 expression at
the DN stages demonstrated significant increases of CD4
levels in mutant thymocytes at DN2, DN3, and DN4 (Fig.
4, B and C). Finally, PCR analysis on mutant CD4 and
CD4 DN3 thymocytes revealed a much higher percent-
age of mutant cells in the CD4 derepressed class than the
CD4 cell population (see Fig. 6, bottom). Taken together,
these data indicate that loss of Brg1 function in developing
thymocytes results in CD4 derepression and a block at the
DN stages of T cell development.
To determine more precisely at which stage the devel-
opmental block occurred in the tBrg mutant mice, DN
thymocytes were subdivided into four distinct develop-
mental stages (DN1, DN2, DN3, and DN4) based on cell
surface expression of CD25 and CD44 expression on TN
thymocytes (Figs. 4 A and 1 C). On a percentage basis,
tBrg1 mice showed a relative increase in TN cells, as
predicted by the loss of the DP population (see above),
and this increased percentage translated into an increase in
absolute terms as the total number of TN cells was signifi-
cantly higher than in controls (Fig. 4 A). Examination of
the DN1→DN4 populations from the mutant thymus re-
vealed the total TN increase was attributed to increased
DN2 and DN3 populations (Fig. 4 A), suggesting a devel-
opmental block and/or increased proliferation at these
stages that should be reflected by decreased or increased
DN4 population, respectively (Fig. 4 A). However, DN4
cell counts were similar in mutant compared with con-
trols. This is most likely explained by CD4 derepression
occurring in mutant thymocytes transitioning from DN2/
DN3→DN4 stages (Fig. 4 B), which would exclude this
population from DN4 cell counts. Given the almost com-
plete deletion of the floxed allele at the DN4 stage, it is
not clear why this population was not uniformly affected
(CD4 derepression). In DN4 cells that have undergone
Figure 3. Block in T cell development at the DN stages
in tBrg1 mice. (A) Flow cytometric analysis of CD4
versus CD8 expression on thymocytes from 4-wk-old
tBrg1 mutant and control littermates. (B) Bar diagram
showing average percentages for CD4 CD8 (DP), CD4
SP, CD8 SP, and CD4 CD8 (DN) subpopulations. Solid
bars represent percentages from control mice (n  9) and
hatched bars represent tBrg1 thymic populations (n  9).
(C) Absolute cell numbers (
107/thymus) for thymocyte
subsets described in B were calculated and are shown as bar
diagrams. Solid bars (control) and hatched bars (tBrg1)
represent average values. *, statistical significance calculated
using the Student’s t test (p-value indicated). (D) Analysis
of TCR (CD3) surface levels in CD4 SP thymocytes in
control (top) versus mutant (bottom). A low percentage of
CD4 SP cells in tBrg1 mice express TCR compared
with controls and therefore constitute immature T cells
that have undergone CD4 derepression.
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Cre-mediated recombination but do not express CD4, it
is likely that residual Brg1 protein–loaded prior loss of the
floxed allele is sufficient to repress CD4 expression at this
stage. Regardless, the remaining DN4 cells were blocked
in differentiation based on the absence of DP cells. In sup-
port of a DN4 to DP block, immature CD8 SP cells, the
immediate precursors of the DP stage, are severely re-
duced in the mutant thymus (Fig. 4 A). Complicating this
interpretation, however, is data implicating the SWI–SNF
complex in direct regulation of CD8 expression (11).
Therefore, it is unclear whether the reductions in cell
numbers at the immature SP stage are due to block before
this stage or fail to activate CD8 expression. Taken to-
gether, these data are consistent with developmental ab-
normalities beginning at the DN2/DN3 stage and subse-
quently with a block at the DN4→DP transition in
tBrg1 thymocytes.
Increased Cell Proliferation and Apoptosis in tBrg1 Imma-
ture Thymocytes. To further investigate the increases in
DN2/DN3 populations and determine the fate of the
CD4 CD3 thymocytes, the proliferative status of mutant
thymocytes was measured through in vivo BrdU incorpo-
ration. In tBrg1 mice, BrdU incorporation was signifi-
cantly higher in both the DN and CD4 derepressed imma-
ture cell populations compared with controls (Fig. 5 A).
Additionally, a slightly higher percentage of DP cells
stained positive for BrdU, however the low numbers of
DP cells present in the mutant thymus make this data unre-
liable. To characterize the proliferative status at the imma-
ture stages, DN cell populations were divided into two
subclasses based on CD44 expression: CD44 (DN12)
and CD44 (DN34). Interestingly, both subclasses
showed an increased percentage of BrdU cells in the mu-
tant thymus (Fig. 5 B), indicating increased cell prolifera-
tion throughout the DN stages. This result is consistent
with the histological observation of increased mitotic fig-
ures in the mutant thymus and increased total cell numbers
at DN2 and DN3 in mutant mice (Figs. 2 H and 4 A).
Although the increased proliferation observed in the
tBrg1 mice is consistent with an increase in total TN
cells (Fig. 4 A), the severe reduction in total thymocytes
present in mutant thymus cannot be fully explained by the
inability of cells to proliferate. Therefore, we used the an-
nexin V staining method to assay the percentage of cells
undergoing apoptosis (21). Analysis of annexin V staining
revealed a slight increase in the percentage of apoptotic
DN thymocytes in mutant compared with controls (Fig. 5
C). Although these differences are unlikely to account for
the massive cell loss in the mutant thymus, examination of
annexin V staining in the mutant CD4 derepressed class
(CD4 CD8 CD3) did demonstrate high percentages of
cells undergoing apoptosis (Fig. 5 C; P  0.01). These data
are consistent with increased numbers of apoptotic bodies
observed through histological analysis (Fig. 2 H). Taken
together, these data suggest that loss of Brg1 triggers an in-
crease in cell proliferation, derepression of CD4, and sub-
Figure 4. Loss of Brg1 derepresses CD4 expression and
induces arrest at the DN stages of thymocyte development.
(A) Flow cytometric analysis of early thymocyte precursors
in control (top) versus tBrg1 mutant (bottom). TN
(CD4 CD8 CD3) cells were analyzed for expression of
CD44 and CD25 (DN1 through DN4 stages, Fig. 1 C).
Bar graph (top right) representing average percentages of
the different subsets DN1, DN2, DN3, and DN4 in control
(solid bars) versus mutant (hatched bars). Lower right bar
graph represents absolute cell numbers (
107) for the subsets
described in Fig. 1 C. tBrg1 mice are represented by
hatched bars (n  3) and control population are repre-
sented by solid bars (n  3). (B) Flow sorting scheme to
investigate CD4 expression at DN stages in control (left)
versus tBrg1 mutant (right). TCR/low cells were sub-
divided into DN1→DN4 (Fig. 1 C, top) and then analyzed
for CD4 expression at the DN3 stage (bottom; reference
11). (C) Bar graph representing percentage of DN
(DN1→DN4) cells that express CD4. Solid bars represent
average value from controls (n  3) and hatched bars
represent average value from tBrg1 mutant (n  3).
*, p-value (Student’s t test).
Gebuhr et al.1943
sequently, programmed cell death at the DN stages of T
cell development.
Brm and pre-TCR Expression Are Independent of Brg1.
Based on the timing and severity of defects in Brg1-defi-
cient thymocyte development, we investigated potential
molecular abnormalities associated with the observed thy-
mic phenotype. Specifically, we examined whether the loss
of Brg1 affected the expression of Brm, another SWI–SNF-
related catalytic subunit often coordinately down-regulated
in human tumor cell lines (22). As shown in Fig. 6, CD4
derepressed DN3 thymocytes exhibit efficient recombina-
tion of the floxed allele, indicating high proportion of mu-
tant cells, but similar levels of Brm expression through
semiquantitative RT-PCR analysis, indicating that Brm ex-
pression is independent of Brg1 and does not contribute to
the severity of the thymic phenotype. Additionally, we ex-
amined the expression of two components of the pre-TCR
complex (TCR and CD3), which, when mutated, block
thymocyte development at the DN3→DN4 transition
(23). Both TCR and CD3 were expressed at similar lev-
els in mutant and control DN3 thymocytes (Fig. 6), sug-
gesting that Brg1 deletion impairs thymocyte developmen-
tal processes downstream of pre-TCR assembly.
Cell Populations in the Periphery of tBrg1 Mice. To as-
sess the degree of developmental block in the thymus and to
determine whether Brg1 function is required for the survival
of mature T cells, we used FACS® on LN and spleen cells to
examine peripheral T cell populations in tBrg1 mice.
Surprisingly, CD4/CD8 staining of peripheral lymphocytes
indicated mature CD4 and CD8 cells present in the pe-
riphery of the mutant animals, although at significantly re-
duced levels, suggesting an incomplete developmental block
in the thymus and/or failure of Cre-mediated recombina-
tion in a low percentage of “escaping” cells. To address this
issue, we performed PCR amplification for the presence of
the deleted floxed allele in whole LN preparations from mu-
tant animals. Results from this analysis demonstrated that
Brg1 mutant cells were present in the LN, suggesting that
the peripheral T cells were not exclusively cells that had es-
caped Cre-mediated recombination (Fig. 7 G).
Although total LN cell counts were similar in mutant
compared with control (Fig. 7 A), TCR cells were re-
duced fourfold in mutant mice with both the CD4 and
Figure 5. Cell proliferation and cell death at immature stages of T cell
development in tBrg1 mice. (A) Bar graph representing average per-
centages of cells staining positive for BrdU incorporation on FACS®.
Immature stages represent control DN (solid bar, n  3), mutant DN
(gray bar, n  3), and mutant CD4 derepressed subpopulation (CD4
CD8 CD3, open bar, n  3). *, statistical significance using Student’s t
test (p-value indicated). (B) Average percentage of BrdU incorporation at
the DN1/DN2 and DN3/DN4 stages in control (solid bar) versus mutant
(hatched bar). (C) Annexin V/PI staining of apoptotic cells on CD4 cells
from mutant versus control (top). Bar graph representation (bottom) of
percentage of cell staining positive for annexin V/PI. Solid bar indicates
percentage of cells from control DN (CD4 CD8, n  3). Hatched bars
indicate percentage of apoptotic cells from tBrg1 mutant in total DN
and CD4 derepressed class (CD4 CD8 CD3, n  3).
Figure 6. Expression analysis of Brg and TCR at the DN3 stage.
RT-PCR measuring Brm, TCR, and CD3 expression in control (C),
mutant (M), CD4 (4), and CD4 (4) DN3 cells.  actin was used as
a control for loading. The bottom represents PCR analysis (described in
Fig. 1 B) to analyze Cre-mediated deletion of the floxed allele in the
DN3 cell populations.
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CD8 populations significantly underrepresented (seven-
fold and 20-fold, respectively; Fig. 7 B). Increased numbers
of B cells and myeloid cells compensate for the reduced
numbers of T cells in the mutant LN and account for the
equivalent total LN cellularity observed (Fig. 7, C and D).
Interestingly, analysis of CD4 and CD8 expression on
CD3 cells revealed a significant increase in DN TCR
cells (CD4 CD8 CD3; Fig. 7 E, middle, and F). This
result could potentially be explained by increased percent-
ages of -TCR (CD4 CD8) T cells due to loss of -
TCR T cells in the periphery. However, calculation of to-
tal DN CD3 T cells indicated an increase in absolute
number of this cell type in tBrg1 compared with con-
trols (1.5  0.2 
 105 vs. 0.6  0.1 
 105; P  0.01).
FACS® analysis for -TCR cells in LN populations re-
vealed that 80  9.4% of mutant DN CD3 cells are -
TCR compared with 28.7  3% in controls. Similarly,
absolute numbers of -TCR T cells were increased in
mutants (1.2  0.12 
 105 in mutant vs. 0.18  0.05 

105 in controls; P  0.01). This result was surprising given
that the size of the -TCR T cell population has been
shown to be regulated independently of the -TCR T
cell population (24). Additionally, significantly higher
numbers of CD4 T cells stained positive for -TCR in
mutant compared with controls (20.1% or 0.15  0.03 

105 vs. 0.05% or 0.07  0.0105 in controls; P  0.05) and
likely represent -TCR T cells that have undergone CD4
derepression (see above). The lck proximal promoter has
been shown to be active at the DN1 stage before /
lineage commitment (Fig. 1 C; reference 25) and raised the
possibility that Brg1 inactivation in these early stages of T
cell development influenced / cell fate decisions in
the thymus. Arguing against this interpretation, absolute
numbers of -TCR cells were not significantly increased
in the mutant thymus (1.45  0.6 
 106 in mutant vs.
1.04  0.3 
 106 in control) and suggested the increase in
-TCR cells in mutants is due to peripheral expansion of
this population. If this expansion in -TCR cells were a
direct result of loss of Brg1 function, a prediction would be
high percentages of Brg1 mutant cells in this cell type.
Therefore, we performed PCR analysis on CD4 CD8
CD3 and DN CD3 flow-sorted populations to test
whether mutant cells contributed exclusively to the DN
CD3 population. This prediction was not borne out ex-
perimentally, however, because both the CD4 SP and the
DN populations amplified with primers specific for the re-
combined floxed allele (Fig. 7 H), indicating mutant cell
contribution to both cell types. To examine relative contri-
bution of mutant cells to these cell populations, we ampli-
fied the unrecombined floxed allele and null alleles (the tar-
geted null mutation and the wild-type allele amplify the
same 230-bp fragment, which is different from the 387-bp
Figure 7. Peripheral T cell populations in tBrg1 mice. (A) Total LN
cell counts represented in bar graph format for control (solid bars, n  9)
and mutant (hatched bars, n  11). (B) Bar graph representation of per-
centages of CD3, CD4, and CD8 cells in control (solid bars, n  9)
and mutant (hatched bars, n  11) LN. (C and D) Percentages of B cells
(B220, C), and myeloid (CD11b, D) are represented in bar graph
format for control (solid bars, n  9) and mutant (hatched bars, n  11).
(E) Flow sorting analysis for CD4 and CD8 expression on CD3 lympho-
cytes (left and middle) revealing increased DN (CD4 CD8 CD3) cell
populations in mutant LNs (middle). Histogram comparing TCR (CD3)
surface levels on mutant and control CD4 cells (right). (F) Average
percentage of CD4, CD8, and CD4 CD8 (DN) on CD3 T cells.
Increased DN percentages in mutant mice are represented by open bar.
CD4 CD3 (solid) and CD8 CD3 (hatched) percentages are shown
for mutant (tBrg1, n  11) and control (n  9). (G and H) Presence of
Brg1 mutant lymphocytes in the periphery. In G, whole LN DNA prepa-
rations from mutant animals were tested for amplification of the  floxed
allele (primer set 1/3). Thymus (Thy) served as a positive control and tail
DNA as a negative control. PCR analysis of flow-sorted CD4 (CD4
CD8 CD3) and CD4 (CD4 CD8 CD3) populations from tBrg1
animals (H) indicated a mixture of mutant cells (bottom) and unrecom-
bined floxed (top) cells in each population.
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fragment for the  floxed allele). Comparison of unrecom-
bined floxed versus wild-type band intensity allowed us to
estimate the percentage of undeleted floxed allele lost due
to Cre-mediated conversion to  flox. We determined
25% of the CD4 CD8 CD3 cells and 40% of the DN
CD3 population were mutant for Brg1. Given that 20% of
CD4 CD8 CD3 and 80% of DN CD3 cells are -
TCR, it raises the possibility that most of the Brg1 mutant
cells are -TCR cells. In this scenario, loss of Brg1 might
be less detrimental to -TCR cells and therefore allows
for survival of this cell type. However, the inability to sep-
arate mutant (undergone Cre-mediated recombination)
and heterozygous (escaped Cre-mediated recombination)
T cells precludes direct examination of TCR or CD4/CD8
expression on mutant T cells. Although, significantly, these
results suggest that, at least in the mature T cell lineage,
Brg1 is not a general cell survival factor. In addition, loss of
Brg1 function in this lineage does not lead to increased in-
cidence of cancer due to the absence of T cell neoplasia
(leukemia and/or lymphomas) in a cohort of mutants aged
over 18 mo.
Functional Characteristics of T Lymphocytes from tBrg1
Mutant Mice. Taking advantage of this “mosaic” (with re-
spect to Brg1 functional status) population of T cells, we
sought to investigate potential T cell functional abnormali-
ties, either cell autonomous or noncell autonomous, attrib-
uted to Brg1 mutation. FACS® analysis of CD4 T lym-
phocytes from tBrg1 mutant mice revealed reduced
surface levels of the TCR (Fig. 7 E), which has been impli-
cated as a hallmark of TCR-mediated activation of T cells
(26). Moreover, expression levels of CD44 and CD69,
markers that are up-regulated upon naive T cell activation,
were found to be increased on these T cells (Fig. 8 A). In
addition to marking activated T cells, CD44 up-regulation
has been shown to persist into the memory pool (27).
Therefore, the dramatic up-regulation observed in tBrg1
Figure 8. Functional characteristics of T lym-
phocytes from tBrg1 mice. (A) FACS® analysis
of CD44 and CD69 on mutant and control CD4
lymphocytes. (B–D) Proliferative response of
whole LN preparation from mutant (hatched bars)
and control (solid bars) LNs using CD3/CD28
antibodies (B), Con A (C), and PMA/Ion (D)
stimulation. (E and F) Hematoxylin and eosin–
stained liver sections from 6-mo-old control (E)
and mutant (F) littermates. Arrows indicate regions
of periportal lymphocyte infiltration.
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peripheral T cells (70% of cells CD44 in mutant vs.
10% CD4 CD44 in controls) indicates that these cells
are effector cells or that they have undergone prior activa-
tion and are memory-like T cells. To distinguish between
these possibilities, we used IL-2R (CD25), another
marker shown to be expressed on activated T cells, in con-
cert with CD44 and CD69, an early marker of activation.
Triple staining experiments indicated a moderate increase
in CD4 CD25 CD44 (78.7  2.1% in mutant vs. 32.8 
2.5% in controls) and CD4 CD25 CD69 (45.0  9.0%
in mutant vs. 31.5  6.0% in controls) cells in mutant mice
(Fig. 8 A). Collectively, these data demonstrate that mature
T cells in the periphery of tBrg1 mice display features
indicative of conversion of naive T cells to activated and/or
memory-like state. Similar memory-like T cell phenotypes
are characteristic of naive T cells that proliferate (called
homeostatic proliferation) in response to conditions of
lymphopenia after adoptive transfer into sublethally irra-
diated or genetically modified T cell–deficient hosts (28).
The severe block in thymocyte development and the low
numbers of DP cells in the tBrg1 mice suggests that the
lymphopenic environment created by Brg1 mutation in the
mouse induces homeostatic proliferation of peripheral T
cells.
To examine the functional consequences of loss of Brg1
function in peripheral mature T cells, we determined in
vitro proliferative responses to a number of stimuli includ-
ing TCR cross-linking using anti-CD3 or anti-CD3 plus
anti-CD28, Con A, and PMA/Ion. Activation of total LN
cells from tBrg1 showed a significant reduction in T cell
proliferative response for CD3 alone or CD3/CD28, two
different concentrations of Con A, and PMA/Ion stimula-
tion when compared with controls (Fig. 8, B–D). Signifi-
cantly, these results indicate that tBrg1 mutant LNs can-
not mount a significant T cell response and therefore can
be classified as immunodeficient mice. Taken together,
these results indicate that in tBrg1 mice, a small number
of mutant and unrecombined heterozygous T cells escape
the developmental block in the thymus and undergo lim-
ited homeostatic proliferation in the periphery that con-
verts them to activated/memory-like T cells. These popu-
lations of T cells do not, however, completely fill the
periphery, which results in immunodeficiency.
Aging of tBrg1 Mice Revealed Low Penetrance Lethality
and Rectal Prolapse. The biological consequence, in terms
of overall animal health, attributed to Brg1 mutation in the
T cell lineage was manifest at weaning (runting; Fig. 2 C)
and throughout subsequent aging over a 12-mo period.
Aging of mutant animals revealed low penetrance lethality.
Roughly 15% of mutant animals (7 out of 49) died prema-
turely over a 12-mo period, whereas no lethality was
observed in littermate control (/floxed; lck-Cre and wild-
type) animals (0 out of 72) over the same period. Further-
more, 20% (11 out of 49 in mutant vs. 0 out of 72 in
controls) of mutant animals exhibited rectal prolapse over
this aging period, although there was no correlation be-
tween the prolapsed rectums and premature lethality phe-
notypes. Based on the immunodeficiency observed in
tBrg1 mice, these whole animal phenotypes were unex-
pected, as other immunologically compromised mice, such
as RAG-deficient and nude mice, thrive in specific patho-
gen-free facilities similar to the one housing tBrg1 mice.
Recently, it has been reported that infection of SCID/Ncr
and nude mice with Helicobacter (Helicobacter hepaticus and
Helicobacter bilis) results in large bowel disease clinically de-
tected by rectal prolapse (29, 30) and, in the case of H. he-
paticus, mild periportal lymphocyte infiltration of the liver
(31). Therefore, we sought to investigate whether endoge-
nous Helicobacter infection was the causative agent of illness
in tBrg1 mice. Indeed, fecal samples from our colony
tested positive for both H. hepaticus and H. bilis using PCR
analysis specific for these pathogenic bacteria (unpublished
data). Moreover, hematoxylin and eosin–stained sections of
mutant liver revealed mild to moderate periportal lympho-
cyte (mixed lineage) infiltration in tBrg1 mice and not
in controls (compare G and H in Fig. 8). These results sug-
gest that endogenous Helicobacter infections contribute to
the health problems in immunodeficiency associated with
Brg1 mutation in the T cell lineage.
Discussion
Considerable interest in ATP-dependent chromatin-
remodeling complexes has focused on delineating biochemi-
cal interactions and molecular mechanisms functioning at
promoters to influence transcriptional regulation. These
studies do not, however, address the function of these
complexes in vivo and significantly less is known about the
function of these complexes in the context of global gene
regulation. The peri-implantation lethality observed in
Brg1 homozygous mutant mice demonstrated the impor-
tance of these complexes in early development but pre-
cluded further functional studies in cell lineages later in
embryogenesis or adults. Here, we provide further insight
into the function of Brg1 in an adult cell lineage by show-
ing that the Brg1 complex is required for T cell develop-
ment at the DN→DP transition but not for cell survival of
mature T lymphocytes.
In tBrg1 mice, abnormalities in thymocyte differenti-
ation are first manifest by an increased number of cells at
the DN2/DN3 stage and subsequently by a block in devel-
opment at the DN4→DP transition. This transition from
DN3→DN4→DP is characterized by  selection check-
points, the importance of which is underscored by muta-
tions in genes involved in these processes. For example,
mutations in the genes involved in TCR rearrangement
(Rag1 and Rag2), assembly of the pre-TCR (TCR, pT,
or CD3), or mediation of the signal transduction cascade
from the pre-TCR (p56lck/p59fyn, Syk/ZAP70, or SLP-76)
results in a block in development at the DN3 stage (23).
Therefore, based on the phenotypic similarities between
these mutants and tBrg1 mice, it is possible that the Brg1
complex(s) plays a role in the  selection process. In sup-
port of this notion, the human SWI–SNF complex was
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shown to stimulate the cleavage and processing of DNA by
RAG1 and RAG2 in V(D)J recombination (32). However,
this is an unlikely explanation for the developmental block
observed in tBrg1 thymocytes because TCR- recom-
bination and expression are unaffected by the loss of Brg1
function (Fig. 6; reference 33). Interestingly, a similar block
beyond the DN3 stage has been found in mice mutant for
N-CoR, a chromatin-modifying complex that has been
shown to contain Brg1, suggesting that the coordinated ef-
fort of multiple chromatin-modifying complexes are re-
quired for transition to the DP stage (34). The loss of the
Brg1–N-CoR complex function is unlikely to fully explain
the tBrg1 phenotype, however, because injection of
anti-CD3, an antibody that mimics pre-TCR signaling,
promotes DN→DP transition in N-CoR thymocytes
whereas in SWI–SNF-related mutant thymocytes it does
not (33, 34). This result implicates the Brg1-containing
complex(s) in mediating events downstream of the pre-
TCR complex.
Signals emanating from the pre-TCR induce the cell
proliferation and differentiation required for transition to
the DP stage, raising the possibility that Brg1 is required
for regulation of genes essential for these processes. In-
deed, BrdU incorporation in tBrg1 thymocytes re-
vealed increased cell proliferation at the DN stages, indi-
cating a cell cycle defect. Interestingly, Brg1 has been
shown to interact with the retinoblastoma (Rb) and cyclin
E gene products, both of which are required for the G1/S
phase transition (35). Based on these data, it has been sug-
gested that Brg1 is a critical regulator of cell cycle progres-
sion and tumor suppression. This notion is consistent with
an increase in total TN thymocytes in mutants, however,
the severe reduction in total thymocytes, owing to an al-
most complete loss of DP cells, suggests a mechanism of
active cell elimination before the DP stage. Indeed, using
CD4 derepression to mark mutant cells, we observed in-
creased apoptotic rates in DN populations, suggesting a
coupling of cell proliferation to programmed cell death. In
addition to the well-established role of Rb loss in tumor
progression, a similar coupling of proliferation to apoptosis
(p53-mediated) has been associated with Rb deficiency in a
variety of cell types in animal models (35). In support of a
similar Rb/E2F/p53 pathway operating in the thymic de-
velopment, disruption of E2F1 leads to suppression of
apoptosis and results in excess mature T cells (36). More-
over, p53 deficiency rescues the block in pre–T cell differ-
entiation associated with CD3 mutation (37). Therefore,
given the interaction between Brg1 and Rb pathway, loss
of Brg1 leading to aberrant Rb function, increased E2F-
mediated transcription, and induction of p53-mediated ap-
optotic pathways provide a plausible explanation for the
defects in thymocyte development in tBrg1 mice.
However, we cannot rule out a role for Brg1 in the cell
survival–independent differentiation program underlying
transition to the DP stage.
Due to the high efficiency of Cre-mediated recombina-
tion at the DN4 stage in /floxed; lck-Cre mice and the se-
verity of developmental block (low numbers of DP cells) in
the thymus of tBrg1 mice, an unexpected result of our
study was the presence of mature T cells in the periphery of
these mutants. These T cell populations were shown to be
a mixture of mutant and heterozygous (unrecombined
floxed) cells, ruling out defective Cre-mediated recombi-
nation as the sole explanation for survival of these T lym-
phocytes. A parsimonious explanation for the survival of
mutant cells is that in a small percentage of thymocytes,
Cre-mediated recombination occurs relatively late in the
DN4 stage and protein stability allows for clearing of key
checkpoints required for further maturation. The mere ex-
istence of mature mutant T cells indicates that in contrast
to developing thymocytes, Brg1 is not required for survival
of this more differentiated cell type. One could argue that
because the Brg1 mutation induced cell death at a highly
proliferative stage of thymocyte development ( selection),
perhaps Brg1 would not be expected for survival in the
more quiescent circulating mature T cell. Arguing against
this view, however, is evidence for homeostatic prolifera-
tion occurring in the lymphopenic environment of tBrg1
mice. Interestingly, homeostatic proliferation of the lim-
ited number of surviving cells did not fully reconstitute pe-
ripheral T cell populations, contrary to the notion that a
single T cell clone stimulated to generate memory T cells
can fill the activated peripheral T cell pool (24, 38). Our
results are consistent with more recent reports showing that
limited numbers of naive T cells cannot fully reconstitute
the periphery (39), indicating that loss of Brg1 in these cells
might not affect homeostasis, per se. The loss of Brg1 func-
tion did not, however, lead to deregulated cell proliferation
and T cell–derived tumor formation in mutant animals
aged over 18 mo, which stands in contrast to the high inci-
dence of CD8 lymphomas observed through conditional
inactivation of SNF5, another SWI–SNF-related complex
member (40). Importantly, this finding supports the notion
that the putative tumor suppressor function associated with
Brg1 loss of function mutations in neoplasms of humans
and mice is tissue and cell type dependent and further, does
not predispose cells of the mature T cell lineage to onco-
genic transformation. Thus, taken together these results
suggest that Brg1 has inherently different functions with re-
spect to cell survival and proliferation at different stages of
T cell lineage specification.
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